A carregar...

Endpoints for Clinical Trials in Young Children with Cystic Fibrosis

The availability of sensitive, reproducible, and feasible outcome measures for quantifying lung disease in children with cystic fibrosis (CF) younger than 6 years is critical to the conduct of clinical trials in this important population. Historically, identifying and quantifying the presence of lun...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Davis, Stephanie D., Brody, Alan S., Emond, Mary J., Brumback, Lyndia C., Rosenfeld, Margaret
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2647606/
https://ncbi.nlm.nih.gov/pubmed/17652509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/pats.200703-041BR
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!